| Novel Imidazo[1,2-a]pyridine Derivatives with Potent Autotaxin/ENPP2 Inhibitor Activity | | monomer | 52-860 | 99.8 | 1×NAG; 1×NAG; 2×ZN; 1×CA; 1×MG; 1×IOD; 3×CL; 1×SCN; 2×PO4; 1×7NB; |
|
| Structural basis for inhibition of human autotaxin by four novel compounds | | monomer | 55-860 | 99.74 | 1×NAG; 2×ZN; 1×CA; 2×NA; 1×4O0; 1×NKN; 7×GOL; 1×CL; |
|
| Crystal structure of autotaxin gamma in complex with LPA 18:1 | | monomer | 55-860 | 99.87 | 1×NAG; 1×5JK; 1×NKP; 9×IOD; 2×CA; 2×ZN; |
|
| Crystal structure of autotaxin gamma and compound MEY-003 | | monomer | 55-860 | 99.87 | 1×NAG; 1×5JK; 1×T8R; 4×GOL; 2×ZN; 21×IOD; 1×CA; |
|
| Structural basis for inhibition of human autotaxin by four novel compounds | | monomer | 57-860 | 99.87 | 1×NAG; 2×ZN; 1×CA; 2×NA; 1×GOL; 1×4NY; 7×SCN; |
|
| Selective Inhibition of Autotaxin is Effective in Mouse Models of Liver Fibrosis | | monomer | 57-860 | 99.87 | 1×NAG; 2×ZN; 1×CA; 1×6Y7; 1×PO4; |
|
| Structural basis for inhibition of human autotaxin by four novel compounds | | monomer | 57-860 | 100.0 | 1×NAG; 1×ZN; 2×CA; 1×EDO; 2×SCN; 1×ACD; 1×4O3; |
|
| Novel Imidazo[1,2-a]pyridine Derivatives with Potent Autotaxin/ENPP2 Inhibitor Activity | | monomer | 57-860 | 99.8 | 1×NAG; 1×7HR; 1×IOD; 2×CL; 1×SCN; 7×NI; 1×PO4; 1×K; 4×ZN; |
|
| Structural basis for inhibition of human autotaxin by four novel compounds | | monomer | 58-860 | 100.0 | 1×NAG; 2×ZN; 1×CA; 2×NA; 2×4O2; 2×EDO; |
|